Track record · biotech
PDUFA calls
by @nadia-perez-11zbv · Dr. Nadia Perez
Each stream is its own gapless, independently verifiable track record. See @nadia-perez-11zbv's full record across every stream ▸
closed = hits + misses + voids · expired-unrevealed is counted and shown separately, never folded into closed outcomes or counted as a loss. This stream carries its own anchor age — a freshly-spun stream is visibly new.
✓ Verify this track is gapless. Every call is chained to the one before it (prev-hash → genesis); a removed or reordered call would break the link. Walk the chain from the latest call back to Nº 1:
/api/v1/verify/by-seq?stream=83452ba5-6e81-471f-bb5a-85f31ad9b73d&seq=8
How the gapless proof works — no Presaid software required
- Fetch call Nº 8 by sequence (link above). It returns that call's commitment and its
prev_hash. - Fetch Nº 7 and confirm its commitment equals the
prev_hashyou just read. - Repeat down to Nº 1 (genesis). The unbroken chain proves no call was inserted, removed, or reordered — the record is complete.
Full method: /docs/verification-spec.
Follow this track as JSON: /api/v1/profiles/nadia-perez-11zbv/streams/pdufa-calls/feed
Every call in this stream
Sequence Nº 1 to 8, contiguous and in order — nothing removable, nothing hidden.
| Nº | Claim | Status | Committed | Deadline | Resolved | Source | |
|---|---|---|---|---|---|---|---|
| 8 | sealed — content not yet revealed | Sealed | 2026-07-06 | 2026-09-04 | — | — | certificate |
| 7 | Axsome's AXS-05 hits its primary endpoint in the Alzheimer's agitation Phase 3 | Hit | 2026-07-06 | 2026-09-04 | 2026-07-06 | self-reported | certificate |
| 6 | Novavax's updated COVID vaccine clears the FDA before September | Miss | 2026-07-06 | 2026-09-04 | 2026-07-06 | self-reported | certificate |
| 5 | Intra-Cellular's ITI-1284 misses on its primary anxiety endpoint in Phase 2 | Miss | 2026-07-06 | 2026-09-04 | 2026-07-06 | self-reported | certificate |
| 4 | Sarepta secures an expanded Elevidys label in Duchenne muscular dystrophy | Hit | 2026-07-06 | 2026-09-04 | 2026-07-06 | self-reported | certificate |
| 3 | Cassava Sciences' simufilam fails its Phase 3 Alzheimer's endpoint | Hit | 2026-07-06 | 2026-09-04 | 2026-07-06 | self-reported | certificate |
| 2 | Lykos' MDMA-assisted PTSD therapy draws a Complete Response Letter, not approval | Hit | 2026-07-06 | 2026-09-04 | 2026-07-06 | self-reported | certificate |
| 1 | Eli Lilly's donanemab wins FDA approval for early Alzheimer's on schedule | Hit | 2026-07-06 | 2026-09-04 | 2026-07-06 | self-reported | certificate |
Cite this track record
A live badge for this stream — its own hit rate and anchor age, linking back to this verifiable track. Copy the HTML or Markdown.
